Table 1.

Comparing MRD detection results by TCR-seq and FC of T-ALL patients.

Patients	DAC	Cancer clonotype in TCR-seq data (%)	T cell percentage by FC (%)	T cell percentage by TCR-seq (%)	MRD by FC (%)	MRD by TCR-seq (%)
CYY	0	85.4	69	27.83	NA	NA
	33	24	12.18	14.36	3.8	3.45
	96	0.45	15.41	13.02	0	0.06
TDJ	8	63.96	ND	29.96	ND	19.16
	15	49.36	32.26	31.74	18.5	15.67
	33	2	15.16	15.30	0	0.31

The TRB CDR3 of cancer clonotype for patients CYY:

TGCAGTGCCTCGCCTCCTCCTAGCGGGAGGGGGAATGAGCAGTTCTTC.

The TRB CDR3 of cancer clonotype for patients TDJ:

TGCAGTGCTAGAGACCTGGGACAGGGGAGCAGGATTAGCTCCTACGAGCAGTACTTC.

DAC, day after beginning of chemotherapy; NA, not applicable; ND, not detection.